CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 184 filers reported holding CLOVIS ONCOLOGY INC in Q2 2015. The put-call ratio across all filers is 1.20 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,513,000 | +748.6% | 42,630 | +97.7% | 0.44% | +553.7% |
| Q1 2016 | $414,000 | -46.9% | 21,560 | -3.1% | 0.07% | -45.5% |
| Q4 2015 | $779,000 | -73.6% | 22,260 | -30.6% | 0.12% | -75.0% |
| Q3 2015 | $2,950,000 | +1.5% | 32,080 | -3.0% | 0.49% | +11.3% |
| Q2 2015 | $2,907,000 | +18.0% | 33,080 | -0.3% | 0.44% | +19.1% |
| Q1 2015 | $2,463,000 | +30.6% | 33,180 | -1.5% | 0.37% | +27.9% |
| Q4 2014 | $1,886,000 | +106.1% | 33,680 | +66.9% | 0.29% | +94.6% |
| Q3 2014 | $915,000 | +36.4% | 20,180 | +24.5% | 0.15% | +30.7% |
| Q2 2014 | $671,000 | +93.9% | 16,210 | +224.2% | 0.11% | +81.0% |
| Q1 2014 | $346,000 | +33.6% | 5,000 | +16.3% | 0.06% | +28.6% |
| Q4 2013 | $259,000 | – | 4,300 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
| Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
| Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
| Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
| NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
| Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
| HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
| Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
| Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
| Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |